a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer
type: MedicalStudy
description: an Single Arm, Single Center Phase II Clinical Study of Shr-1210 Combined With Paclitaxel-albumin and Carboplatin in the First-line Treatment of Extensive Stage Small Cell Lung Cancer
status: UNKNOWN
study design: INTERVENTIONAL
phase: PHASE2
start date: 2021-04-01
end date: 2022-12-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT04790539
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Shanghai Pulmonary Hospital, Shanghai, China
study subject: Extensive Stage Small Cell Lung Cancer
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: UNKNOWN
keywords: Extensive Stage Small Cell Lung Cancer

AI Analytics
type: Organization